Dr Niamh Buckley is working to develop a treatment for triple negative breast cancer, using technology similar to that used in the COVID-19 vaccine.

Dr Ross Chapman is investigating the potential of drugs called PLK inhibitors to treat breast cancer with a genetic change that is found in around 10% of cases.

Breast cancer can trick nearby immune system cells to help the disease to grow, spread and resist treatment. Dr Ali Roghanian aims to understand how breast cancer cells communicate with these immune cells and how we can stop this.

Professor Ester Hammond is studying how changing oxygen levels in triple negative breast cancer can make the disease more aggressive and likely to spread. 

Dr Thomas A Hughes is testing an additional treatment that could make chemotherapy more effective. This could stop breast cancer from coming back and spreading and help save lives.

Professor Michael Dixon is researching how to identify and better treat oestrogen receptor positive (ER+) breast cancers that don’t respond to hormone therapy.